Search

Jose A Halperin

from Brookline, MA
Age ~78

Jose Halperin Phones & Addresses

  • 1443 Beacon St, Brookline, MA 02446 (617) 277-6807
  • 101 Arch St, Boston, MA 02110
  • Roslindale, MA
  • Cambridge, MA
  • 1443 Beacon St APT 711, Brookline, MA 02446 (617) 750-2570

Work

Company: Lap For Translational Address: 1 Kendall Sq, Cambridge, MA 02139 Phones: (617) 621-6136

Education

School / High School: Universidad De Buenos Aires, Facultad De Ciencias Medicas 1972

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 1989

Specialities

Internal Medicine

Professional Records

Medicine Doctors

Jose Halperin Photo 1

Dr. Jose A Halperin, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Internal Medicine
Address:
75 Francis St, Boston, MA 02115
(617) 632-3000 (Phone)

Lap For Translational
1 Kendall Sq, Cambridge, MA 02139
(617) 621-6136 (Phone)
Certifications:
Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
75 Francis St, Boston, MA 02115

Lap For Translational
1 Kendall Sq, Cambridge, MA 02139

Brigham and Women's Hospital
75 Francis Street, Boston, MA 02115
Education:
Medical School
Universidad De Buenos Aires, Facultad De Ciencias Medicas
Graduated: 1972
Jose Halperin Photo 2

Jose Alberto Halperin

View page
Specialties:
Internal Medicine
Hematology
Education:
Universidad De Buenos Aires (1971)
Jose Halperin Photo 3

Jose Alberto Halperin, Boston MA

View page
Specialties:
Internist
Address:
75 Francis St, Boston, MA 02115
Education:
University of Buenos Aires, Faculty of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine

Resumes

Resumes

Jose Halperin Photo 4

Professor

View page
Location:
Cambridge, MA
Industry:
Environmental Services
Work:
Center For Health and the Global Environment at Harvard Medical School
Professor
Jose Halperin Photo 5

Founder

View page
Location:
Brookline, MA
Industry:
Medical Devices
Work:
Mellitus
Founder
Jose Halperin Photo 6

Jose Halperin

View page
Jose Halperin Photo 7

Jose Halperin

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jose Halperin
Manager
MELLITUS, LLC
Cambridge Innovation Ctr, Cambridge, MA 02142
Jose Halperin
Manager
ACH SCIENCES, LLC
1443 Beacon St #711, Brookline, MA 02446
Jose Alberto Halperin
Jose Halperin MD
Internist
75 Francis St, Boston, MA 02115
(617) 732-6345
Jose Halperin
Director
Best Doctors
Health, Wellness and Fitness · Management Consulting Services
100 Federal Street, 21, Boston, MA 02110
100 Federal St, Boston, MA 02110
1 Boston Pl, Boston, MA 02108
(617) 226-3616, (617) 723-2534, (800) 362-8677
Jose A. Halperin
Internal Medicine
Hms Lab for Translational Research
Nonclassifiable Establishments
1 Kendall Sq, Cambridge, MA 02139
20 Shattuck St, Boston, MA 02115

Publications

Us Patents

Substituted Diphenyl Indanone, Indane And Indole Compounds And Analogues Thereof Useful For The Treatment Of Prevention Of Diseases Characterized By Abnormal Cell Proliferation

View page
US Patent:
6043272, Mar 28, 2000
Filed:
Nov 20, 1997
Appl. No.:
8/975391
Inventors:
Carlo Brugnara - Newton Highlands MA
Jose Halperin - Brookline MA
Rudolf Fluckiger - Brookline MA
Emile Bellot - Beverly MA
Richard John Lombardy - Littleton MA
John J. Clifford - Arlington MA
Reem M. Haidar - Woburn MA
Eugene W. Kelleher - Somerville MA
Adel M. Moussa - Burlington MA
Yesh P. Sachdeva - Concord MA
Minghua Sun - Libertyville IL
Heather N. Taft - Littleton MA
Assignee:
Ion Pharmaceuticals, Inc. - New York NY
President and Fellows of Harvard College - Cambridge MA
Children's Medical Center Corporation - Boston MA
International Classification:
A61K 31335
C07C25500
C07C 6976
C07C 6952
US Classification:
514467
Abstract:
The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Substitute 11-Phenyl-Dibenzazepine Compounds Useful For The Treatment Or Prevention Of Diseases Characterized By Abnormal Cell Proliferation

View page
US Patent:
6534497, Mar 18, 2003
Filed:
Sep 22, 2000
Appl. No.:
09/554848
Inventors:
Carlo Brugnara - Newton Highlands MA
Jose Halperin - Brookline MA
Rudolf Fluckiger - Brookline MA
Richard John Lombardy - Littleton MA
John J. Clifford - Bedford MA
Reem M. Haidar - Woburn MA
Eugene W. Kelleher - Somerville MA
Adel M. Moussa - Burlington MA
Yesh P. Sachdeva - Concord MA
Minghua Sun - Cambridge MA
Heather N. Taft - Littleton MA
Michael H. Zeldin - Cambridge MA
Assignee:
Nuchem Pharmaceuticals, Inc. - Markham
Childrens Medical Center Corporation - Boston MA
Presidents and Fellows of Harvard College - Cambridge MA
International Classification:
C07D22320
US Classification:
514217, 540587
Abstract:
The present invention provides substituted 11-phenyl-dibenzazepine compounds that are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Substituted Diphenyl Indanone, Indane And Indole Compounds And Analogues Thereof Useful For The Treatment Of Prevention Of Diseases Characterized By Abnormal Cell Proliferation

View page
US Patent:
6800658, Oct 5, 2004
Filed:
Jan 10, 2002
Appl. No.:
10/043640
Inventors:
Carlo Brugnara - Newton Highlands MA
Jose Halperin - Brookline MA
Rudolf Fluckiger - Brookline MA
Richard John Lombardy - Littleton MA
John J. Clifford - Arlington MA
Reem M. Haidar - Woburn MA
Eugene W. Kelleher - Somerville MA
Adel M. Moussa - Burlington MA
Yesh P. Sachdeva - Concord MA
Minghua Sun - Cambridge MA
Heather N. Taft - Littleton MA
Assignee:
Childrens Medical Center Corporation - Cambridge MA
President Fellows of Harvard College - Cambridge MA
Nuchem Pharmaceuticals, Inc.
International Classification:
C07C 2200
US Classification:
514467, 514475, 514544, 514546, 514640, 514617, 514717, 549430, 549453, 549550, 558388, 560 56, 560 57, 560221, 564180, 564265
Abstract:
The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Methods, Products And Treatments For Diabetes

View page
US Patent:
6835545, Dec 28, 2004
Filed:
Apr 16, 2001
Appl. No.:
09/835752
Inventors:
Jose Halperin - Brookline MA
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
G01N 3353
US Classification:
435 71, 5303875, 53038825
Abstract:
The invention involves assays, diagnostics, kits, and assay components for determining levels of K41-glycated CD59 in subjects. Treatments for subjects based upon levels of K41-glycated CD59 also are provided.

Substituted 11-Phenyl-Dibenzazepine Compounds Useful For The Treatment Or Prevention Of Diseases Characterized By Abnormal Cell Proliferation

View page
US Patent:
6992079, Jan 31, 2006
Filed:
Dec 7, 2001
Appl. No.:
10/013308
Inventors:
Carlo Brugnara - Newton Highlands MA, US
Jose Halperin - Brookline MA, US
Rudolf Fluckiger - Brookline MA, US
Richard John Lombardy - Littleton MA, US
John J. Clifford - Arlington MA, US
Reem M. Haidar - Woburn MA, US
Eugene W. Kelleher - Medford MA, US
Adel M. Moussa - Burlington MA, US
Yesh P. Sachdeva - Concord MA, US
Minghua Sun - Libertyville IL, US
Heather N. Taft - Littleton MA, US
Michael H. Zeldin - Cambridge MA, US
Assignee:
President Fellows of Harvard College - Cambridge MA
Children's Medical Center Corporation - Boston MA
NuChem Pharmaceuticals Inc. - Toronto
International Classification:
A61K 31/55
C07D 233/18
US Classification:
514217, 540587
Abstract:
The present invention provides substituted 11-phenyl-dibenzazepine compounds which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Methods, Products And Treatments For Diabetes

View page
US Patent:
7049082, May 23, 2006
Filed:
Apr 28, 2004
Appl. No.:
10/833581
Inventors:
Jose Halperin - Brookline MA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
G01N 33/53
US Classification:
435 71, 435975
Abstract:
The invention involves assays, diagnostics, kits, and assay components for determining levels of K41-glycated CD59 in subjects. Treatments for subjects based upon levels of K41-glycated CD59 also are provided.

Substituted Diphenyl Indanone, Indane And Indole Compounds And Analogues Thereof Useful For The Treatment Or Prevention Of Diseases Characterized By Abnormal Cell Proliferation

View page
US Patent:
7342038, Mar 11, 2008
Filed:
Jun 1, 2004
Appl. No.:
10/858975
Inventors:
Carlo Brugnara - Newton Highlands MA, US
Jose Halperin - Brookline MA, US
Rudolf Fluckiger - Brookline MA, US
Richard John Lombardy - Littleton MA, US
John J. Clifford - Bedford MA, US
Reem M. Haidar - Woburn MA, US
Eugene W. Kelleher - Somerville MA, US
Adel M. Moussa - Burlington MA, US
Yesh P. Sachdeva - Concord MA, US
Minghua Sun - Cambridge MA, US
Heather N. Taft - Littleton MA, US
Assignee:
President and Fellow of Harvard College - Cambridge MA
Children's Medical Center Corporation - Boston MA
NuChem Pharmaceuticals Inc. - Toronto
International Classification:
C07D 209/10
C07D 209/12
A61K 31/404
US Classification:
514415, 548469, 548483, 548490
Abstract:
The present invention provides substituted 3,3-diphenyl indole compounds, as well as analogues thereof, which are specific potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Anti-Glycated Cd59 Antibodies And Uses Thereof

View page
US Patent:
7439330, Oct 21, 2008
Filed:
Jun 17, 2004
Appl. No.:
10/870342
Inventors:
Jose Halperin - Brookline MA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
C07K 16/40
G01N 33/53
US Classification:
5303882, 5303891, 5303913, 435 79
Abstract:
The invention includes antibodies or antigen-binding fragments thereof which bind specifically to glycated CD59, compositions containing one or a combination of such antibodies or antigen-binding fragments thereof, hybridoma cell lines that produce the antibodies, and methods of producing and using the antibodies or antigen-binding fragments thereof for diagnosis and treatment of diabetic conditions and diabetic-associated conditions.
Jose A Halperin from Brookline, MA, age ~78 Get Report